A major advance in cancer research is occurring with the use of VHH fragments to re-engage mutated p53. This essential tumor suppressor protein is frequently disabled in many types of tumors, leading uncontrolled cell https://top10bookmark.com/story21800917/mini-antibodies-revive-the-p53-protein-new-potential-hope-for-malignant-therapy